Seminars in Nuclear Medicine

Papers
(The TQCC of Seminars in Nuclear Medicine is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Theranostics in Lung Neuroendocrine Tumors158
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update125
Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques78
Imaging of Invasive Fungal Infections- The Role of PET/CT73
Letter from the Editors62
PET/CT in the Imaging of CNS Tumors58
Non-FDG hypoxia tracers55
New Promising Targets for Imaging in Cardiovascular Diseases54
FAPI-PET in Cardiovascular Disease46
Autoimmune Thyroid Diseases45
Sentinel Lymph Node Methods in Breast Cancer44
Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies43
The Value of FDG PET/CT in Penile Cancer: An Update41
Artificial Intelligence for Drug Discovery: An Update and Future Prospects40
Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer39
CD70-Targeted Radiotheranostics: Now and Future38
The Role of Nuclear Medicine in Benign Thyroid Disease38
Letter from the Editors38
Imaging for Radiation Planning in Breast Cancer38
Selective Internal Radiotherapy in Liver Tumors: Early Promise Yet to be Fulfilled37
Prognostic Value of PSMA PET/CT in Prostate Cancer37
Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy37
Global experience in brain amyloid imaging35
Molecular Imaging in Inflammatory Bowel Disease35
Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects34
Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity33
Total-Body PET/CT: A Role of Artificial Intelligence?31
The Evolution of Artificial Intelligence in Nuclear Medicine31
Artificial intelligence for tumor [18F]FDG-PET imaging: Advancement and future trends—part I30
Imaging of Cardiac Sarcoidosis: An Update and Future Aspects29
Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma29
New Approaches for Imaging Bacteria28
The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis28
Remote Reading and Teaching of Nuclear Medicine in the Era of COVID-1928
PET/MR Technology: Advancement and Challenges27
Expanding Role for Gallium-68 PET Imaging in Oncology25
Letter From the Editors24
Use of Radionuclide-Based Imaging Methods in Breast Cancer24
18F-Fluoride PET/CT—Updates24
Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices23
Update on Pediatric Nuclear Medicine in Acute Care23
The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma23
Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine23
Standardized PSMA-PET Imaging of Advanced Prostate Cancer22
Radiolabeled Somatostatin Analogs for Cancer Imaging21
Total-body PET/CT – First Clinical Experiences and Future Perspectives21
Recent Advances and Future Trends of[18F]-Labeled PET Agents for Renal Imaging21
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology21
Nuclear Medicine Preclinical Research: The Role of Cell Cultures20
FDG PET/CT for Staging Lung Carcinoma: An Update20
Impact of COVID-19 on Nuclear Medicine in Asia20
Practice of 18F-FDG-PET/CT in ICU Patients: A Systematic Review20
18F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases19
Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?19
FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview19
Functional Imaging of Testicular Torsion18
The Impact of PSMA PET/CT Imaging in Prostate Cancer Radiation Treatment18
Safe Pulmonary Scintigraphy in the Era of COVID-1918
Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine18
Artificial Intelligence Augmented Cerebral Nuclear Imaging18
The Clinical Utility of Molecular Imaging in COVID-19: An Update18
Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends17
Artificial Intelligence and Workforce Diversity in Nuclear Medicine17
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?17
Targeted Radiopharmaceutical Therapy for Bone Metastases17
Development of PSMA-Targeted Alpha Therapy Using [211At]PSMA-516
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET16
The Impact of COVID-19 on Nuclear Medicine in Europe16
Molecular Imaging for Response Assessment of Neuroendocrine Tumors (NET)16
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma16
Radiomics and Artificial Intelligence Landscape for [18F]FDG PET/CT in Multiple Myeloma15
Telehealth in Multidisciplinary Target Delineation for Radiotherapy During the COVID-19 Pandemic. A Review and a Case15
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers Part II. [F]F-FLT, [F]F-FET, [C]C-MET and Other Less-Commonly Used Radiotrace15
Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy15
Total-Body PET/CT Metabolic Response in Esophageal Squamous Cell Carcinoma15
A Role of Non-FDG Tracers in Lung Cancer?15
Letter from the Editors15
Sentinel Node Mapping in Penile Cancer: An Update on Methods and Pitfalls15
Current Developments on [18F]FDG PET/CT in Inflammatory Disorders of the Central Nervous System14
Letter From the Guest Editors14
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides14
FDG-PET/CT of COVID-19 and Other Lung Infections14
Letter From the Editors14
Radiolabeled Antibody–Drug Conjugates in the Treatment of Solid Tumors14
Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging14
Prostate Cancer Theranostics With 177Lu-PSMA14
Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine14
Neuroimaging of Mild Traumatic Injury14
Advances in PET/CT Technology: An Update14
COVID-19 Pandemic: What Have We Learned and What to Expect in the Future?14
0.66500997543335